Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariane Laparra

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Brain Communications|October 15, 2021
Neurological complications induced by immune checkpoint inhibitors: a comprehensive descriptive case-series unravelling high risk of long-term sequelaeLéo Plaçais, Jean-Marie Michot, Stéphane Champiat, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2025
Infectious Complications in Patients Treated with T-cell Engagers as Cancer Immunotherapies, A Descriptive Study from the REISAMIC RegistryThomas Hueso, Justin Cagnat, Kaïssa Ouali, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2021
Outcomes of patients with cancer and sarcoid-like granulomatosis associated with immune checkpoint inhibitors: A case-control studyCharlotte Cabanié, Samy Ammari, Sophie Hans, et al.
American Journal of Respiratory Cell and Molecular Biology|October 10, 2025
Macrophage CCL18 Promotes Lung Inflammation in Checkpoint Inhibitor PneumonitisMohammad I Ghanbar, Andres Villabona-Rueda, Nicolas Philip, et al.
European Journal of Cancer (Oxford, England : 1990)|December 6, 2022
Immune-related generalised oedema - A new category of adverse events with immune checkpoint inhibitorsMaud Velev, Barouyr Baroudjian, Roxane Pruvost, et al.
Rheumatology (Oxford, England)|March 26, 2025
Immune checkpoint inhibitors-induced large vessel vasculitis: clinical characteristics and management from a European multicentre studyAdrien Cottu, Laure Delaval, Alexandra Forestier, et al.
Cancer Discovery|February 18, 2022
The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy IndividualsJean-Eudes Fahrner, Imran Lahmar, Anne-Gaëlle Goubet, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Brain Communications|October 15, 2021
Neurological complications induced by immune checkpoint inhibitors: a comprehensive descriptive case-series unravelling high risk of long-term sequelaeLéo Plaçais, Jean-Marie Michot, Stéphane Champiat, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2025
Infectious Complications in Patients Treated with T-cell Engagers as Cancer Immunotherapies, A Descriptive Study from the REISAMIC RegistryThomas Hueso, Justin Cagnat, Kaïssa Ouali, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2021
Outcomes of patients with cancer and sarcoid-like granulomatosis associated with immune checkpoint inhibitors: A case-control studyCharlotte Cabanié, Samy Ammari, Sophie Hans, et al.
American Journal of Respiratory Cell and Molecular Biology|October 10, 2025
Macrophage CCL18 Promotes Lung Inflammation in Checkpoint Inhibitor PneumonitisMohammad I Ghanbar, Andres Villabona-Rueda, Nicolas Philip, et al.
European Journal of Cancer (Oxford, England : 1990)|December 6, 2022
Immune-related generalised oedema - A new category of adverse events with immune checkpoint inhibitorsMaud Velev, Barouyr Baroudjian, Roxane Pruvost, et al.
Rheumatology (Oxford, England)|March 26, 2025
Immune checkpoint inhibitors-induced large vessel vasculitis: clinical characteristics and management from a European multicentre studyAdrien Cottu, Laure Delaval, Alexandra Forestier, et al.
Cancer Discovery|February 18, 2022
The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy IndividualsJean-Eudes Fahrner, Imran Lahmar, Anne-Gaëlle Goubet, et al.
Pageof 3